David Coman - Aug 12, 2022 Form 4 Insider Report for Science 37 Holdings, Inc. (SNCE)

Role
Chief Executive Officer
Signature
/s/ Christine Pellizzari, Attorney-in-fact for David Coman
Stock symbol
SNCE
Transactions as of
Aug 12, 2022
Transactions value $
$0
Form type
4
Date filed
8/16/2022, 04:13 PM
Previous filing
Jan 11, 2022
Next filing
May 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNCE Restricted Stock Units Award $0 +1.49M $0.00 1.49M Aug 12, 2022 Common Stock 1.49M Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Science 37 Holdings, Inc.'s common stock.
F2 On August 12, 2022, Mr. Coman received restricted stock units representing 1,485,365 shares subject to a three-year vesting schedule, vesting 33 1/3% on the first, second and third anniversaries of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.